SCHEMBL26069745

SCHEMBL26069745

CCc1cc(C(F)(F)F)nc(N)n1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.58
HSP90AB1 P08238 1/20 0.58
KDM4E B2RXH2 5/20 0.46
HSD17B10 Q99714 2/20 0.46
ALDH1A1 P00352 2/20 0.44
HRH3 Q9Y5N1 5/20 0.43
PTGS2 P35354 1/20 0.43
GRM4 Q14833 1/20 0.41
NOS3 P29474 1/20 0.41
NOS2 P35228 1/20 0.41
HRH4 Q9H3N8 2/20 0.39
HEXA P06865 1/20 0.37
HEXB P07686 1/20 0.37
MAPT P10636 1/20 0.35
PDPK1 O15530 1/20 0.35
CA2 P00918 1/20 0.34
CHKA P35790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27966418 0.82 HSP90AA1 (0.51) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1
SCHEMBL10900625 0.79 HSP90AA1 (0.71) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1
SCHEMBL1576980 0.79 NOS3 (0.54) HSP90AB1KDM4EHRH3NOS3NOS2
SCHEMBL31453692 0.77 CYP2C19 (0.40) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1
SCHEMBL21928738 0.74 NOS2 (0.52) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1
SCHEMBL21731116 0.74 HSP90AA1 (0.37) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1
SCHEMBL21212228 0.74 CYP2D6 (0.38) HSP90AA1HSP90AB1KDM4ENOS3NOS2
SCHEMBL5361699 0.74 HSP90AA1 (1.00) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1
SCHEMBL218379 0.74 HRH3 (0.46) HRH3NOS3NOS2HRH4HEXA
SCHEMBL28447815 0.73 KDM4E (0.57) HSP90AA1HSP90AB1KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4234548-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) 2023-08-30 EP disclosed